Aytu BioPharma, Inc. (AYTU) vs GridAI Technologies Corp. (GRDX)
A side-by-side comparison of Aytu BioPharma, Inc. and GridAI Technologies Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AYTU
Aytu BioPharma, Inc.
$2.09HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
GRDX
GridAI Technologies Corp.
$3.96HealthcareDelayed quote: Oct 6, 2026, 10:01 AM EDT
Total return — AYTU vs GRDX
growth of $100 · dividends reinvested · last 10yAYTU -100.0% (-68.5%/yr)GRDX -100.0% (-69.9%/yr)AYTU compounded faster over this window
AYTU GRDX
AYTU vs GRDX: by the numbers
- •GRDX is the larger company ($28M vs $22M market cap).
- •Both run net losses; AYTU's is the smaller (-24.76% vs -12789.65% net margin).
Metrics side by side
Valuation
| Metric | AYTU | GRDX |
|---|---|---|
| P/S ratio | 0.39 | 175.90 |
| P/B ratio | 0.64 | 1.95 |
| FCF yield | 14.50% | N/A |
Profitability
| Metric | AYTU | GRDX |
|---|---|---|
| Gross margin | 63.95% | -3398.93% |
| Operating margin | -14.44% | -19539.98% |
| Net margin | -24.76% | -12789.65% |
| ROE | -40.40% | -111.81% |
| ROIC | -14.21% | -42.23% |
Growth (annualized)
| Metric | AYTU | GRDX |
|---|---|---|
| Revenue CAGR (5Y) | -2.59% | N/A |
| Total return CAGR (5Y) | -48.14% | -83.84% |
Frequently asked
- How have AYTU and GRDX total returns compared?
- Over the past 5 years, AYTU delivered -48.14% and GRDX delivered -83.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aytu BioPharma ROEGridAI Technologies ROEAytu BioPharma operating marginGridAI Technologies operating marginAytu BioPharma revenue growthGridAI Technologies revenue growthAytu BioPharma free cash flowGridAI Technologies free cash flow
Aytu BioPharma & GridAI Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.